Regulating Opioid Prescribing Through Prescription Monitoring Programs: Balancing Drug Diversion and Treatment of Pain

Opioid therapy and prescription drug diversion.

Prescription Drug Monitoring Programs and Other Interventions to Combat Prescription Opioid Abuse

The Center for Disease Control and Prevention (CDC) has published significant data and trends related to opioid prescription pain relievers (OPR). In 2008, 20,044 deaths were attributed to prescription drug overdose of which 14,800 (73.8%) were due to OPR, an amount greater than the number of overdose deaths from heroin and cocaine combined. The majority of these deaths were unintentional. Betw...

Preventing Prescription Drug Diversion.

THE FACTS In 2013, more than 43,900 Americans died from drug overdose. Prescription drugs contributed to most of those deaths. Opioid pain relievers like oxycodone, hydrocodone, and methadone were involved in more than 16,000 of those deaths (Centers for Disease Control and Prevention [CDC], 2015). Approximately 46 Americans die every day from drug overdoses (Jones, Mack, & Paulozzi, 2013). Opi...

Prescription Drug Monitoring Programs: Evolution and Evidence

This Issue Brief reviews the current status and characteristics of PDMPs, their use, and evidence of their effectiveness. It summarizes best practices for PDMPs and the needs for further research and evaluation.

Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program.

Objective Prescription drug monitoring programs (PDMPs) were created to facilitate responsible use of controlled substances. In Oregon, physicians, physician's assistants (MDs/DOs/PAs), dentists, nurse practitioners (NPs), and naturopathic physicians (NDs) may prescribe opioids, but differences in prescribing practices, patient mix, and patient outcomes among prescriber types have not been char...